Benefits of Joints² and Bones¹ Card

Key Findings

• A nutraceutical combination containing glucosamine sulfate, chondroitin sulfate, methylsulfonylmethane (MSM), and omega-3 fatty acids significantly reduced pain and stiffness and improved physical function in patients with knee osteoarthritis. Over 12 weeks, mean pain scores decreased from 7.2 to 2.8, while WOMAC scores improved from 56.3 to 33.7 [1].
• Daily supplementation with hydrolysed type II collagen, MSM, glucosamine sulfate, and chondroitin sulfate for eight weeks significantly improved knee pain and functional outcomes in individuals with Grade 1–3 knee osteoarthritis. Patient adherence was high, with median compliance of 96.77% [2].
• Glucosamine sulfate and chondroitin sulfate may help preserve articular cartilage and slow structural changes associated with osteoarthritis. Some clinical studies have reported significantly less cartilage loss compared with placebo, although the clinical relevance and consistency of these effects remain uncertain [3][4].

Introduction

Osteoarthritis is a common degenerative joint condition characterised by pain, stiffness, reduced mobility, and progressive changes in cartilage, bone, and surrounding joint tissues. Conventional treatments primarily focus on symptom control, but long-term use of certain medicines may be associated with side effects or limited tolerability [1][5].

Nutraceutical ingredients are increasingly being investigated as complementary options for supporting joint comfort, cartilage integrity, mobility, and bone health. Compounds such as glucosamine sulfate, chondroitin sulfate, MSM, type II collagen, omega-3 fatty acids, vitamins, and minerals may act through different but complementary mechanisms, including structural support, modulation of inflammatory processes, and contribution to normal bone and connective tissue metabolism [1][6][7].

The Joints² & Bones¹ Card combines omega-3 fish oil, vitamin E, calcium, magnesium, type II collagen, bamboo-derived silica, manganese, zinc, vitamin K2, vitamin D3, vitamin C, glucosamine sulfate, chondroitin sulfate, and MSM. This report reviews the available scientific evidence supporting the potential contribution of these ingredients to joint comfort, mobility, cartilage health, and normal bone maintenance.

Main Text

Clinical Evidence for Joint Comfort and Mobility

Several clinical studies have evaluated combinations of glucosamine, chondroitin, MSM, collagen, and omega-3 fatty acids in individuals with knee osteoarthritis.

A prospective interventional study involving 80 patients with radiologically confirmed primary knee osteoarthritis, classified as Kellgren–Lawrence Grade II or III, investigated a combination of glucosamine sulfate, chondroitin sulfate, MSM, and omega-3 fatty acids over 12 weeks [1].

Participants experienced significant improvements in both pain and physical function. The mean Visual Analogue Scale pain score decreased from 7.2 ± 1.1 at baseline to 2.8 ± 0.9 after 12 weeks, representing an approximate 61% reduction in reported pain. The total Western Ontario and McMaster Universities Osteoarthritis Index score decreased from 56.3 ± 8.5 to 33.7 ± 6.4, corresponding to an improvement of approximately 40% [1].

These findings indicate that a multi-ingredient nutraceutical approach may provide meaningful symptomatic support for individuals with knee osteoarthritis.

A separate observational, non-interventional study included 98 patients, with a mean age of 52.8 ± 6.5 years, who had Grade 1–3 knee osteoarthritis. Participants received a daily supplement containing:

• 1,250 mg hydrolysed type II collagen
• 750 mg MSM
• 750 mg glucosamine sulfate
• 400 mg chondroitin sulfate

After eight weeks, significant improvements were observed in Visual Analogue Scale pain scores, WOMAC scores, and Health Assessment Questionnaire scores. All reported changes reached statistical significance, and median patient compliance was 96.77% [2].

The results suggest that combined supplementation may support pain reduction and physical function while being well accepted by patients.

Glucosamine and Chondroitin Sulfate

Glucosamine and chondroitin are naturally occurring compounds associated with cartilage structure and extracellular matrix function. They are among the most extensively studied nutraceutical ingredients for osteoarthritis.

A systematic review of randomised controlled trials evaluated whether glucosamine and chondroitin could protect articular cartilage and delay osteoarthritis progression. Among the included studies:

• three of four trials investigating chondroitin sulfate reported a significant reduction in cartilage loss, and
• two of three trials investigating glucosamine reported significant structural effects compared with placebo [3].

These findings suggest a potential chondroprotective effect. However, clinical guidelines remain cautious because the magnitude and consistency of benefits for pain, physical function, and structural modification vary between studies [4].

Some evidence suggests that chondroitin may provide short-term symptomatic benefits, particularly during treatment periods of less than three months. Nevertheless, uncertainty remains regarding the long-term clinical significance of these effects [4].

Glucosamine sulfate, chondroitin sulfate, and undenatured type II collagen act through different molecular pathways. Their combined use may provide complementary effects by supporting cartilage metabolism, modulating inflammatory activity, and enhancing the effects of conventional pain-management strategies [5][8].

MSM and Type II Collagen

MSM is an organosulfur compound commonly used in joint-support formulations. It has been investigated for its potential to support joint comfort and modulate inflammatory and oxidative processes.

Clinical evidence indicates that MSM may be particularly useful when combined with glucosamine, chondroitin, and collagen. In the eight-week observational study described above, a combination containing MSM and hydrolysed type II collagen significantly improved pain and functional scores in patients with knee osteoarthritis [2].

Type II collagen is a major structural protein in articular cartilage and contributes to its strength, resilience, and biomechanical properties. Both hydrolysed and undenatured forms of collagen have been studied for joint support.

Clinical trials investigating hydrolysed collagen have reported improvements in:

• joint discomfort,
• mobility,
• physical function, and
• selected indicators of joint structure [6][10].

Marine collagen has also attracted interest because of its bioavailability, biocompatibility, and biological activity, although the clinical evidence varies according to collagen source, dosage, and formulation [10].

Omega-3 Fatty Acids and Vitamin E

Omega-3 polyunsaturated fatty acids are widely recognised for their role in modulating inflammatory pathways. In osteoarthritis, inflammatory mediators may contribute to pain, cartilage degradation, and reduced joint function.

A narrative review concluded that omega-3 fatty acids may help moderate pro-inflammatory biomarkers and processes associated with cartilage loss in osteoarthritis [9].

The clinical study combining omega-3 fatty acids with glucosamine, chondroitin, and MSM reported substantial improvements in pain and function over 12 weeks, although the study design does not allow the effects of omega-3 to be separated from those of the other ingredients [1].

Vitamin E provides antioxidant protection by helping protect cells and tissues from oxidative stress. Oxidative processes are involved in cartilage ageing and joint tissue damage, meaning that antioxidant nutrients may provide complementary nutritional support within a joint-health formulation.

Vitamins and Minerals Supporting Bone and Connective Tissue

Normal bone and connective tissue metabolism depends on an adequate supply of vitamins and minerals. The Joints² & Bones¹ Card includes several nutrients with established physiological roles in bone maintenance and collagen formation.

Vitamin C

Vitamin C contributes to normal collagen formation for the normal function of cartilage and bones. Collagen is a major structural component of cartilage, bone matrix, tendons, and ligaments.

Insufficient vitamin C impairs collagen synthesis and may weaken connective tissue integrity [6][11].

Vitamin D3 and Calcium

Vitamin D contributes to the maintenance of normal bones and supports the normal absorption and utilisation of calcium and phosphorus. Calcium is a major structural mineral in bone and is required for maintaining normal bone density and strength [11][12][13].

The combined presence of vitamin D3 and calcium therefore provides complementary support for normal bone metabolism.

Vitamin K2

Vitamin K contributes to the maintenance of normal bones. It is involved in the activation of proteins associated with bone mineralisation and calcium regulation.

Although the studies reviewed did not directly assess vitamin K2 within the complete Joints² & Bones¹ Card formulation, its recognised role in normal bone maintenance supports its inclusion in a bone-health supplement.

Magnesium, Zinc, and Manganese

Magnesium contributes to the maintenance of normal bones and supports normal muscle function. Zinc contributes to the maintenance of normal bones and is involved in protein synthesis and cellular repair.

Manganese contributes to the normal formation of connective tissue and helps protect cells against oxidative stress. These minerals may therefore provide complementary support for bone, cartilage, and connective tissue health [6][11].

Bamboo-Derived Silica

Silica is commonly included in connective tissue and bone-support formulations. Bamboo extract is a concentrated natural source of silica.

Silica has been investigated for its possible role in collagen formation, connective tissue structure, and bone mineralisation. However, the literature supplied for this report does not provide formulation-specific clinical evidence for bamboo silica within the Joints² & Bones¹ Card.

Evidence from Preclinical Research

Preclinical research has also explored multi-ingredient combinations designed to support cartilage and bone repair.

In a rabbit osteochondral defect model with osteoarthritis-like changes, a capsule containing bovine hydroxyapatite, gelatin, vitamin D3, and chondroitin sulfate improved cartilage architecture and increased bone-cell counts [14].

Although animal studies cannot be directly translated into clinical effects in humans, these findings provide mechanistic support for combining structural materials, vitamin D3, and chondroitin in formulations intended to support cartilage and bone tissue.

Limitations and Considerations

The available evidence suggests that several ingredients included in the Joints² & Bones¹ Card may support joint comfort, mobility, cartilage integrity, and normal bone metabolism. However, important limitations should be considered.

Many of the clinical studies evaluated multi-ingredient formulations, making it difficult to determine the individual contribution of each component. Differences in ingredient form, dose, duration, osteoarthritis severity, and study design may also affect outcomes.

The evidence for glucosamine and chondroitin remains mixed. While some studies have reported reductions in cartilage loss and improvements in symptoms, clinical guidelines note uncertainty regarding the magnitude and long-term relevance of these benefits [3][4].

In addition, the complete combination contained in the Joints² & Bones¹ Card has not been evaluated in a dedicated clinical trial. Conclusions regarding the full formulation are therefore based on studies of individual ingredients or related nutraceutical combinations.

Supplementation should be regarded as a complementary approach and not as a replacement for medical diagnosis, physical therapy, appropriate exercise, weight management, or prescribed osteoarthritis treatment.

Conclusion

The available scientific literature supports the potential contribution of several ingredients included in the Joints² & Bones¹ Card to joint comfort, physical function, cartilage support, and normal bone health.

Clinical studies investigating combinations of glucosamine sulfate, chondroitin sulfate, MSM, omega-3 fatty acids, and type II collagen have reported substantial improvements in pain, stiffness, and functional mobility in individuals with knee osteoarthritis [1][2].

In one 12-week study, mean pain scores decreased by approximately 61%, while WOMAC scores improved by approximately 40% following supplementation with glucosamine sulfate, chondroitin sulfate, MSM, and omega-3 fatty acids [1]. An eight-week study evaluating hydrolysed type II collagen, MSM, glucosamine sulfate, and chondroitin sulfate also reported significant improvements in pain and function, with high patient compliance [2].

Glucosamine and chondroitin may provide structural support for articular cartilage and could help limit cartilage loss in some individuals, although the clinical evidence is not fully consistent and the long-term significance remains uncertain [3][4].

Additional ingredients—including vitamin C, vitamin D3, vitamin K2, calcium, magnesium, zinc, manganese, omega-3 fatty acids, and collagen—have complementary roles in collagen formation, bone maintenance, connective tissue health, antioxidant protection, and normal inflammatory regulation.

Although the complete Joints² & Bones¹ Card formulation has not been investigated as a single regimen, the available evidence for its individual ingredients and related combinations suggests a multifaceted approach to supporting joint mobility, cartilage integrity, connective tissue, and normal bone health.

References

1. Deepak Kumar Singh et al. Evaluation of Symptomatic Relief and Functional Improvement with Nutraceutical Supplementation in Osteoarthritis: A Clinical Study from a Tertiary Care Hospital in Bihar. International Journal of Pharmaceutical Quality Assurance (2025). https://impactfactor.org/PDF/IJPQA/16/IJPQA,Vol16,Issue2,Article57.pdf
2. FF Ayhan et al. The Effect of Combined Hydrolysed Type 2 Collagen, Methylsulfonylmethane, Glucosamine Sulfate and Chondroitin Sulfate Supplementation on Knee Osteoarthritis Symptoms. Turkish Journal of Physical Medicine and Rehabilitation (2024). https://pubmed.ncbi.nlm.nih.gov/38948650/
3. B Gallagher et al. Chondroprotection and the Prevention of Osteoarthritis Progression of the Knee: A Systematic Review of Treatment Agents. The American Journal of Sports Medicine (2014). https://pubmed.ncbi.nlm.nih.gov/24866892/
4. NHG Guidelines. Clinical guidance concerning glucosamine and chondroitin use in osteoarthritis.
5. O. A. Gromova et al. On the Use of Chondroitin Sulfate, Glucosamine Sulfate and Undenatured Type II Collagen for Back and Limb Pain and Osteoarthritis. Neurology, Neuropsychiatry, Psychosomatics (2022). https://nnp.ima-press.net/nnp/article/view/1931
6. I. S. Dydykina et al. The Optimal Way to Fill the Deficiency of Essential Substances for the Well-being of the Joints. Medical Council (2022). https://www.med-sovet.pro/jour/article/view/6959
7. D Apostu et al. Systemic Drugs with Impact on Osteoarthritis. Drug Metabolism Reviews (2019). https://pubmed.ncbi.nlm.nih.gov/31726891/
8. Article Editorial et al. Pharmaconutraceutical Chondroguard® TRIO—A New Ideology for the Prevention of Musculoskeletal Diseases and Nutritional Support for Patients with Osteoarthritis and Nonspecific Back Pain: An Assessment of Clinical Options. Modern Rheumatology Journal (2023). https://mrj.ima-press.net/mrj/article/view/1420
9. DM Cordingley et al. Omega-3 Fatty Acids for the Management of Osteoarthritis: A Narrative Review. Nutrients (2022). https://pubmed.ncbi.nlm.nih.gov/36014868/
10. D. I. Trukhan et al. Hydrolysed Marine Collagen in Complex Therapy of Degenerative-Dystrophic Changes in the Musculoskeletal System. Clinical Review for General Practice (2023). https://klin-razbor.ru/en/archive/2023/vol-4-8-2023/hydrolyzed-marine-collagen-in-complex-therapy-of-degenerative-dystrophic-changes-in-the-mustocular-s_6547/?element
11. C Palacios et al. The Role of Nutrients in Bone Health, from A to Z. Critical Reviews in Food Science and Nutrition (2006). https://pubmed.ncbi.nlm.nih.gov/17092827/
12. B Tokhiriyon et al. New Biocomplex for Nutrient-Metabolic Support of Bone Tissue. IOP Conference Series: Earth and Environmental Science (2019). https://doi.org/10.1088/1755-1315/315/3/032020/
13. A. A. Vekovtsev et al. Clinical Trials of the Vitamin-Mineral Complex for the Treatment of Children with a Trauma Profile. Proceedings of the Voronezh State University of Engineering Technologies (2019). https://www.vestnik-vsuet.ru/vguit/article/view/2213
14. F Deapsari et al. Integrated Physicochemical and Therapeutic Assessment of Bovine Hydroxyapatite–Gelatin–Vitamin D3–Chondroitin Sulfate Capsules in a Rabbit Osteochondral Defect Model with Osteoarthritis-Like Changes. Scientific Reports (2026). https://pubmed.ncbi.nlm.nih.gov/42014487/